scispace - formally typeset
M

Mark Ashworth

Researcher at King's College London

Publications -  279
Citations -  6537

Mark Ashworth is an academic researcher from King's College London. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 37, co-authored 245 publications receiving 5284 citations. Previous affiliations of Mark Ashworth include University of Cambridge.

Papers
More filters
Journal ArticleDOI

How are primary care organizations using financial incentives to influence prescribing

TL;DR: It is concluded that larger prescribing incentive scheme payments may have contributed to prescribing cost control but their effect on prescribing quality is uncertain.
Journal ArticleDOI

Enhanced motivational interviewing for reducing weight and increasing physical activity in adults with high cardiovascular risk: the MOVE IT three-arm RCT.

TL;DR: Enhanced MI, in group or individual formats, targeted at members of the general population with high CVD risk is not effective in reducing weight or increasing PA compared with UC, and the group and individual interventions were not cost-effective.
Journal ArticleDOI

Sphygmomanometer calibration: a survey of one inner-city primary care group.

TL;DR: Survey of all sphygmomanometers in current use in one inner city primary care group found inaccuracy rates were lower than in other reported community surveys, and the implication is that all practices need to have procedures in place for the regular calibration of their sphyGMomanometers.
Journal ArticleDOI

Prescribing incentive schemes in two NHS regions: cross sectional survey.

TL;DR: Results show that financial rewards to general practices could be linked more explicitly to improvements in the quality and appropriateness of prescribing than under fundholding schemes, and some categories were used to indicate both quality and cost.
Journal ArticleDOI

Probability of sepsis after infection consultations in primary care in the United Kingdom in 2002-2017: Population-based cohort study and decision analytic model.

TL;DR: Risks of sepsis and benefits of antibiotics are more substantial among older adults, persons with more advanced frailty, or following UTIs, and stratified estimates of risk help to identify groups in which antibiotic prescribing may be more safely reduced.